ILSI-Biomed Israel

Long-Awaited Bilski Decision Expected Soon

by GERSON PANITCH, FINNEGAN   June 14, 2010 Patent professionals and U.S. Supreme Court watchers alike on high alert as a Bilski decision is expected before the Court’s 2009 term comes to an end this month.  Perhaps no case is more anticipated than the decision in Bilski v. Doll, especially for those in high-tech fields such as telecom, software, and professional services.  Over a year has passed since the Supreme Court agreed to hear Bilski’s appeal (June 1, 2009), and more than seven ...

ILSI-BioMed 2010 Has Begun!

This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad. Following the opening words of the event's organizers, ILSI and Kenes, the president of Israel Shimon Peres came up to the stage and surveyed the future of Israel, which will be based on advanced technologies and serve as an example to the entire...

Networking with Five Italian Companies

Five Italian biomedical companies are coming to Israel, and are interested in meeting suitable Israeli business partners It’s not WHAT you know, it’s WHO you know! Relationships are the catalyst for success! Do the above two statements look familiar? They should. They are the axioms of the Networking Theory (name not trademarked, invented on the spot). While networking seems to be the new religion of the business folks, I daresay that it’s been around for quite a bit. Even apes have...

Medtronic buys ATS: Cardiology Shopping Spree Is Not Over

Last week Medtronic announced its plan to acquire the American ATS Medical for $370 million in cash and debt - an offer that represents a 54 percent premium over ATS Medical’s closing price of $2.54 the day before. The move is supposed to strengthen Medtronic's position in the expanding cardiovascular market. It adds to a series of purchases made by the medical device giant in the last two years, paying a total of more than $2 Billion. In 2009, Medtronic has spent over $1 billion to ...

May 5th: Healthcare Reform Webinar

U.S. Health Care Reform Webinar - A Special Presentation for Israeli Pharma, Biotech and Medical Device Companies and Their Investors     Please register for this live webinar.   Meeting Description:    Drug and Biologics Manufacturers: Medicare and Medicaid drug coverage changes Annual fee for branded prescription drug manufacturers Biosimilars   Medical Device Manufacturers: Excise tax Essential Health Benefits Package   Heal...

May 11th: Seminar on Advantages of Manufacturing in Israel

SAVE THE DATE May 11th, 16:00-19:00 Beit Chel Ha’avir, 15  Jabotinski Street, Herzelia Advantages of Manufacturing in Israel The seminar will focus on issues related to options, advantages and Governmental policies associated with manufacturing of Medical Devices and Biopharma products in Israel.  The event will be moderated by Moshe Mizrahy, founder of Nitzanim Medical Fund  Agenda 16:00-16:20           Moshe Mizrahy - Introduction 16:20-16:40           Dr. Ora Dar, ...

Plastics that Distort DNA Readings

A new research reveals that polypropylene tubes can contaminate solutions in the PCR and distort the DNA spectrometer readings. One year ago, a group of researchers at Hadassah-Hebrew University Medical Center in Jerusalem reported a sharp rise in the diagnoses of a certain metabolic disorder. To those of us who live in Jerusalem, fear not. Other than the Holyland story, nothing really happened in the Israeli capital in the last year. The only change is that the lab at Hadassah changed th...

The Potential of Smart-phones in Biomedicine

Medical apps for iPhone can be found aplenty, and soon to come are biomedical apps that interact with implants and monitor vital signs. A few weeks ago I received my first iPhone, and ever since I’ve had a blast of a time. This single, tiny device, can take the place of so many other utilities: books, movie and music players and yes – even portable game systems. It all depends on the apps you choose to download to your iPhone, of which there is a wide variety. Of all the applications I ve...

Meet the Speakers: The Future of siRNA

siRNA is one of the molecules of future medicine, with some success at early clinical trials. How will this molecule affect the future of therapeutics? Twelve years ago, a novel mechanism for shutting down genes has been described in a nature paper. The mechanism described made use of molecules called siRNA – Small Inhibitory RNA – whose potential for the development of new therapies for diseases like cancer has been recognized immediately. Last year, Dr. Dan Peer managed to create lip...

The Law of the Ordinary and Contact Lenses against Glaucoma

A new invention in the form of contact lenses against glaucoma, shows how biomedical devices should be designed I like to think about biomedical instruments as bits of magic. Not because they cause wonders and provide instant-cures (though some do), but because the more ordinary and mundane in appearance they are, the better they become – much as in magic tricks. It’s the Law of the Ordinary ™. If you market a device for overcoming seizures, and it looks like a robotic arm-sleeve, the...